20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7570 | RGD peptide (GRGDNP) | RGD peptide GRGDNP(2TFA),RGD peptide GRGDNP | Apoptosis , Integrin |
RGD peptide (GRGDNP) (RGD peptide GRGDNP(2TFA)) is a integrin-ligand interactions inhibitor. | |||
TP1311 | RGD peptide (GRGDNP) (TFA) (114681-65-1 free base) | RGD peptide (GRGDNP) (TFA) | |
RGD peptide (GRGDNP) (TFA) promote apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing. | |||
T81283 | RGD-targeted Proapoptotic Peptide | ||
RGD-Targeted Proapoptotic Peptide is a peptide that preferentially binds to integrins at sites of tumor angiogenesis through its C-terminal RGD-4C sequence (ACDCRGDCFC). | |||
T76007 | RGD peptide (GRGDNP) (TFA) | ||
RGD peptide (GRGDNP) TFA functions as an inhibitor of integrin-ligand interactions, competitively blocking α5β1's interaction with the extracellular matrix (ECM). It induces apoptosis by triggering conformational changes... | |||
T7566L | GRGDSPK 2TFA(111119-28-9(free base)) | EMD 56574 | Others |
GRGDSPK 2TFA(111119-28-9(free base)) (EMD 56574) is an inhibitory peptide for RGD-mediated adhesion between integrin and extracellular matrix molecules. | |||
TP1290 | GRGDSP acetate(91037-75-1 free base) | GRGDSP TFA | Integrin |
GRGDSP acetate(91037-75-1 free base) is a synthetic linear RGD peptide and is an integrin inhibitor. | |||
TP1458L | Arg-Gly-Glu-Ser acetate(93674-97-6 free base) | Others | |
Arg-Gly-Glu-Ser acetate is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets. | |||
TP1330 | Cyclo(RADfK) | Integrin | |
Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.Cyclo(RADfK) is a negative control for the cyclo (-RGDfK-), the RGD peptide. RGD... | |||
TP1696L | CGGRGD acetate(1260223-44-6 free base) | Others | |
CGGRGD acetate is a RGD derivative with cysteine as the n-terminal. CGGRGD was synthesized by solid phase peptide synthesis technology, and amino2-cyanobenzothiazole (2-cyanobenzothiazole) (2-cyanobenzothiazole (CBT) was... | |||
TP1530L | YRGDS Fibronectin Fragment acetate | YRGDS Fibronectin Fragment acetate(134282-68-1 free base) | Others |
YRGDS Fibronectin Fragment acetate (YRGDS Fibronectin Fragment acetate (134282-68-1 free base))(134282-68-1 free base) is a fibronectin fragment acetate, an adhesion peptide that displays strong binding affinity to throm... | |||
TP1474 | LXW7 | Integrin | |
LXW7 is an octamer disulfide cyclic peptide and αvβ3 integrin ligand, acts as a potent and specific endothelial progenitor cells (EPCs) and endothelial cells (ECs) targeting ligand. LXW7 is a disulfide cyclic octa-pepti... | |||
T24796 | SK&F 107260 | Skf107260,Skf-107260,Skf 107260 | |
SK&F 107260 is an RGD-containing peptide. It is a potent GP IIb/IIIa antagonist and a vitronectin antagonist. | |||
T24896 | TP 9201 | TP-9201,TP9201 | |
TP 9201 is a platelet integrin alphaIIbbeta3 antagonist. It is a synthetic RGD-containing cyclic peptide. | |||
TP1530 | YRGDS Fibronectin Fragment | ||
This is a fibronectin fragment, an adhesion peptide that displays strong binding affinity to thrombin-stimulated platelets. It is RGD consisting of sequence. | |||
T7566 | GRGDSPK | EMD 56574 | Others |
GRGDSPK (EMD 56574) is an inhibitory peptide for RGD-mediated adhesion between integrin and extracellular matrix molecules. | |||
TP1421 | GRGDSP | ||
Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) is used as a soluble integrin-blocking RGD-based peptide. | |||
T80075 | Cyclo(Ala-Arg-Gly-Asp-Mamb) | XJ735 | Integrin |
Cyclo(Ala-Arg-Gly-Asp-Mamb) is a selective antagonist of the RGD peptide with potential applications in pulmonary arterial hypertension research [1]. | |||
TP1489 | Risuteganib | ||
Risuteganib is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide that regulates the functions of multiple integrin isoforms. | |||
T78001 | Arg-Gly-Glu-Ser TFA | ||
Arg-Gly-Glu-Ser TFA, an RGD-related peptide, serves as a control for evaluating the inhibitory activity of RGDS on fibrinogen binding to activated platelets. | |||
TP1458 | Arg-Gly-Glu-Ser | ||
Arg-Gly-Glu-Ser is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets. |